Paul Langerhans Institute Dresden becomes a member of DRESDEN-concept

Starting 1 January 2024, the Paul Langerhans Institute Dresden (PLID) has become a full member of DRESDEN-concept, a research alliance of 37 partner institutions, including TUD Dresden University of Technology and non-university research and cultural institutions from the Dresden region.

The Paul Langerhans Institute Dresden (PLID) is a founding partner of the German Center for Diabetes Research at the University Hospital Dresden, a satellite institute of Helmholtz Munich since 2015 and one of the three German Centers for Health Research in Dresden. Research at the PLID focuses on the islets of Langerhans in the pancreas. These islets contain the insulin-producing beta cells, which are impaired or even destroyed in type 1, type 2 and gestational diabetes. The research groups in the PLID are working on deciphering the mechanisms that cause the destruction and/or functional impairment of beta cells in diabetes. They are also developing new approaches to replace the damaged or destroyed beta cells. Their efforts extend also to research on other organs perturbed in metabolic disorders, such as the liver, the adipose tissue as well as the innate and acquired immune system.

Membership of DRESDEN-concept offers PLID the opportunity for more intensive collaboration and exchange with other research institutions in Dresden. This integration promises deeper networking and strengthens PLID’s position as a major player in diabetes research in Germany.